Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Merit Medical Systems	Haemonetics	NuVasive	Cantel Medical	AtriCure
Symbol	NASDAQ:MMSI	NYSE:HAE	NASDAQ:NUVA	NYSE:CMD	NASDAQ:ATRC
Price Information
Current Price	$59.68	$51.81	$68.59	$83.93	$70.46
52 Week Range	Buy	Buy	Hold	Hold	Buy
MarketRank™
Overall Score	1.7	1.9	1.2	1.3	1.7
Analysis Score	2.4	3.3	1.2	1.0	3.5
Community Score	2.7	2.2	2.7	2.4	2.9
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	1.7	1.7	0.0	1.7	1.7
Earnings & Valuation Score	1.9	2.5	1.9	1.3	0.6
Analyst Ratings
Consensus Recommendation	Buy	Buy	Hold	Hold	Buy
Consensus Price Target	$67.00	$115.40	$68.43	$71.50	$79.14
% Upside from Price Target	12.27% upside	122.74% upside	-0.24% downside	-14.81% downside	12.32% upside
Trade Information
Market Cap	$3.34 billion	$2.63 billion	$3.54 billion	$3.74 billion	$3.22 billion
Beta	1.21	0.56	1.36	1.54	1.13
Average Volume	275,050	704,220	712,722	511,980	401,790
Sales & Book Value
Annual Revenue	$994.85 million	$988.48 million	$1.17 billion	$1.02 billion	$230.81 million
Price / Sales	3.36	2.66	3.03	3.68	13.93
Cashflow	$3.59 per share	$2.29 per share	$6.72 per share	$3.70 per share	N/A
Price / Cash	16.64	22.59	10.20	22.69	N/A
Book Value	$17.21 per share	$11.67 per share	$17.58 per share	$17.31 per share	$6.25 per share
Price / Book	3.47	4.44	3.90	4.85	11.27
Profitability
Net Income	$5.45 million	$76.53 million	$65.23 million	$13.71 million	$-35,190,000.00
EPS	$1.46	$3.31	$2.47	$1.65	($1.07)
Trailing P/E Ratio	N/A	25.03	N/A	99.92	N/A
Forward P/E Ratio	32.09	14.76	29.31	28.84	N/A
P/E Growth	2.40	5.17	1.79	1.57	N/A
Net Margins	-3.05%	11.76%	-0.84%	3.38%	-21.74%
Return on Equity (ROE)	9.02%	22.85%	8.00%	11.19%	-14.83%
Return on Assets (ROA)	4.91%	10.40%	3.06%	4.10%	-7.77%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	-25.00%	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.37%	0.44%	0.85%	1.28%	0.15%
Current Ratio	2.34%	2.25%	1.85%	3.13%	6.62%
Quick Ratio	1.21%	1.34%	1.48%	2.31%	5.85%
Ownership Information
Institutional Ownership Percentage	99.47%	96.22%	N/A	95.01%	94.70%
Insider Ownership Percentage	4.70%	1.63%	0.89%	10.70%	5.80%
Miscellaneous
Employees	5,989	3,004	2,700	3,669	750
Shares Outstanding	56.00 million	50.82 million	51.65 million	44.51 million	45.63 million
Next Earnings Date	8/4/2021 (Estimated)	N/A	8/3/2021 (Estimated)	6/3/2021 (Estimated)	7/27/2021 (Estimated)
Optionable	Optionable	Optionable	Optionable	Optionable	Optionable

Source	Headline
	AtriCure, Inc. (NASDAQ:ATRC) Director Scott William Drake Sells 4,631 Shares americanbankingnews.com - May 11 at 12:11 PM
	Scott William Drake Sells 38,641 Shares of AtriCure, Inc. (NASDAQ:ATRC) Stock americanbankingnews.com - May 11 at 12:11 PM
	AtriCure (NASDAQ:ATRC) Shares Gap Down to $77.67 americanbankingnews.com - May 11 at 10:56 AM
	Business Outlook for Peripheral Interventions Market 2021 by Abbott Laboratories, AtriCure Inc., AngioDynamics, Inc – Clark County Blog - Clark County Blog clarkcountyblog.com - May 11 at 7:50 AM
	Form 4 AtriCure, Inc. For: May 05 Filed by: Lanning Mark R - StreetInsider.com streetinsider.com - May 7 at 6:41 PM
	AtriCure (NASDAQ:ATRC) Hits New 12-Month High at $80.20 americanbankingnews.com - May 7 at 12:44 PM
	Form 4 AtriCure, Inc. For: May 03 Filed by: WEHRWEIN SVEN - StreetInsider.com streetinsider.com - May 5 at 2:05 PM
	Insider Selling: AtriCure, Inc. (NASDAQ:ATRC) Director Sells 10,000 Shares of Stock americanbankingnews.com - May 5 at 11:14 AM
	AtriCure (NASDAQ:ATRC) PT Raised to $102.00 americanbankingnews.com - May 4 at 11:12 AM
	AtriCure (NASDAQ:ATRC) Given New $75.00 Price Target at Oppenheimer americanbankingnews.com - May 4 at 10:36 AM
	Global Atrial Fibrillation Drugs Market 2025: Top Key Players AtriCure Inc., CardioFocus Inc. and others – FLA News - FLA News flanewsonline.com - May 4 at 10:35 AM
	AtriCure (NASDAQ:ATRC) Releases FY 2021 Earnings Guidance americanbankingnews.com - May 4 at 9:22 AM
	AtriCure (NASDAQ:ATRC) Price Target Raised to $81.00 at Needham & Company LLC americanbankingnews.com - May 4 at 8:46 AM
	AtriCure, Inc. (NASDAQ:ATRC) Expected to Post Earnings of -$0.33 Per Share americanbankingnews.com - May 3 at 6:46 PM
	AtriCure's EPi-Sense system approved by US FDA for treatment of long-standing persistent AF - Cardiac Rhythm News cardiacrhythmnews.com - May 1 at 8:25 AM
	Is AtriCure Inc. (ATRC) a Leader in the Healthcare Sector? - InvestorsObserver investorsobserver.com - May 1 at 12:56 AM
	AtriCure (NASDAQ:ATRC) Lowered to "Hold" at Zacks Investment Research marketbeat.com - April 30 at 4:40 PM
	The Wait Is Over — FDA Approves Device for Long-Standing Persistent Afib - Medical Device and Diagnostics Industry mddionline.com - April 30 at 9:56 AM
	AtriCure (ATRC) Soars 8.8%: Is Further Upside Left in the Stock? - Yahoo Finance finance.yahoo.com - April 30 at 9:56 AM
	Atricure scores win at FDA with atrial fibrillation solution - BioWorld Online bioworld.com - April 30 at 9:56 AM
	Can You Imagine How Elated AtriCure's (NASDAQ:ATRC) Shareholders Feel About Its 427% Share Price Gain? finance.yahoo.com - April 30 at 9:56 AM
	AtriCure (ATRC) Soars 8.8%: Is Further Upside Left in the Stock? finance.yahoo.com - April 30 at 9:56 AM
	AtriCure Inc. (ATRC) PT Raised to $91 at Needham & Company on FDA Approval - StreetInsider.com streetinsider.com - April 29 at 7:23 PM
	AtriCure (NASDAQ:ATRC) PT Raised to $85.00 americanbankingnews.com - April 29 at 6:48 PM
	Is AtriCure Inc. (ATRC) a Smart Choice in Medical Instruments & Supplies Thursday? - InvestorsObserver investorsobserver.com - April 29 at 2:22 PM
	Stocks Showing Rising Market Leadership: Atricure Earns 81 RS Rating - Investor's Business Daily investors.com - April 29 at 2:22 PM

Date	Company	Brokerage	Action
5/6/2021	Merit Medical Systems	Raymond James	Boost Price Target
5/6/2021	Merit Medical Systems	Needham & Company LLC	Boost Price Target
4/30/2021	Merit Medical Systems	Barrington Research	Boost Price Target
2/26/2021	Merit Medical Systems	Canaccord Genuity	Boost Price Target
11/11/2020	Merit Medical Systems	Wells Fargo & Company	Boost Price Target
11/11/2020	Merit Medical Systems	Oppenheimer	Boost Price Target
10/29/2020	Merit Medical Systems	Sidoti	Boost Price Target
10/29/2020	Merit Medical Systems	Piper Sandler	Boost Price Target
4/26/2021	Haemonetics	Morgan Stanley	Reiterated Rating
4/19/2021	Haemonetics	CJS Securities	Downgrade
1/21/2021	Haemonetics	JMP Securities	Boost Price Target
4/27/2021	NuVasive	Truist	Boost Price Target
3/31/2021	NuVasive	Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell	Boost Price Target
12/16/2020	NuVasive	Smith Barney Citigroup	Upgrade
10/30/2020	NuVasive	BTIG Research	Downgrade
8/19/2020	Cantel Medical	Bank of America	Initiated Coverage
4/29/2021	AtriCure	SVB Leerink	Reiterated Rating
7/29/2020	AtriCure	JPMorgan Chase & Co.	Boost Price Target

(Data available from 5/14/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources